Carlyle
Latest statistics and disclosures from Carlyle Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QDEL, SLNO, ZI, PHAT, QTTB, and represent 85.33% of Carlyle Group's stock portfolio.
- Added to shares of these 5 stocks: FWRD, Exicure, CART, AVGO, SMHI.
- Started 3 new stock positions in CART, FWRD, Exicure.
- Reduced shares in these 10 stocks: QDEL (-$149M), ZI (-$58M), GDS (-$38M), VRNA (-$36M), AON, NU, DASH, AIU, CSLR, XCUR.
- Sold out of its positions in DASH, EFTR, XCUR, GDS, AIU, VRNA, AON, NU.
- Carlyle Group was a net seller of stock by $-276M.
- Carlyle Group has $954M in assets under management (AUM), dropping by -9.38%.
- Central Index Key (CIK): 0001527166
Tip: Access up to 7 years of quarterly data
Positions held by Carlyle consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Carlyle Group
Carlyle Group holds 26 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Quidel Corp (QDEL) | 39.5 | $377M | -28% | 8.3M | 45.60 |
|
Soleno Therapeutics (SLNO) | 21.5 | $205M | 4.1M | 50.44 |
|
|
ZoomInfo Technologies Common Stock (ZI) | 12.6 | $120M | -32% | 12M | 10.32 |
|
Phathom Pharmaceuticals (PHAT) | 6.6 | $63M | 3.5M | 18.07 |
|
|
Q32 Bio (QTTB) | 5.1 | $49M | 1.1M | 44.09 |
|
|
Getty Images Holdings Cl A Com (GETY) | 3.7 | $35M | 9.2M | 3.81 |
|
|
Jasper Therapeutics Com New (JSPR) | 2.1 | $20M | 1.1M | 18.66 |
|
|
Invitation Homes (INVH) | 1.8 | $17M | 478k | 35.26 |
|
|
Complete Solaria (CSLR) | 1.4 | $14M | 4.9M | 2.81 |
|
|
Seacor Marine Hldgs (SMHI) | 1.3 | $13M | 1.3M | 9.65 |
|
|
Cubesmart (CUBE) | 1.2 | $12M | 221k | 53.83 |
|
|
Reneo Pharmaceuticals (RPHM) | 0.5 | $4.5M | 2.7M | 1.68 |
|
|
Adicet Bio (ACET) | 0.4 | $4.2M | 2.9M | 1.44 |
|
|
Forward Air Corporation (FWRD) | 0.4 | $4.1M | NEW | 107k | 38.41 |
|
Krispy Kreme (DNUT) | 0.4 | $3.7M | 341k | 10.74 |
|
|
Smart Sh Global Ads (EM) | 0.4 | $3.4M | 4.8M | 0.71 |
|
|
Hillevax (HLVX) | 0.3 | $3.2M | 1.8M | 1.76 |
|
|
Spruce Biosciences (SPRB) | 0.1 | $1.3M | 2.9M | 0.46 |
|
|
N-able Common Stock (NABL) | 0.1 | $1.2M | 94k | 13.06 |
|
|
Solarwinds Corp Com New (SWI) | 0.1 | $1.2M | 94k | 13.05 |
|
|
Exicure | 0.1 | $972k | NEW | 56k | 17.25 |
|
Broadcom (AVGO) | 0.1 | $586k | +349% | 3.4k | 172.50 |
|
Maplebear (CART) | 0.1 | $558k | NEW | 14k | 40.74 |
|
Nucana Sponsored Adr (NCNA) | 0.0 | $304k | 133k | 2.28 |
|
|
Spyre Therapeutics Com New (SYRE) | 0.0 | $282k | 9.6k | 29.36 |
|
|
Molecular Templates Com New (MTEM) | 0.0 | $19k | 13k | 1.40 |
|
Past Filings by Carlyle Group
SEC 13F filings are viewable for Carlyle Group going back to 2012
- Carlyle Group 2024 Q3 filed Nov. 8, 2024
- Carlyle Group 2024 Q2 filed Aug. 9, 2024
- Carlyle Group 2024 Q1 filed May 3, 2024
- Carlyle Group 2023 Q4 filed Feb. 2, 2024
- Carlyle Group 2023 Q3 filed Nov. 3, 2023
- Carlyle Group 2023 Q2 filed Aug. 4, 2023
- Carlyle Group 2023 Q1 filed May 5, 2023
- Carlyle Group 2022 Q4 filed Feb. 10, 2023
- Carlyle Group 2022 Q3 filed Nov. 10, 2022
- Carlyle Group 2022 Q2 filed Aug. 12, 2022
- Carlyle Group 2022 Q1 filed May 13, 2022
- Carlyle Group 2021 Q4 filed Feb. 11, 2022
- Carlyle Group 2021 Q3 filed Nov. 12, 2021
- Carlyle Group 2021 Q2 filed Aug. 12, 2021
- Carlyle Group 2021 Q1 filed May 14, 2021
- Carlyle Group 2020 Q4 filed Feb. 12, 2021